Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 302

1.
2.

[CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].

Wang ZS, Wu LQ, Yi X, Geng C, Li YJ, Yao RY, Hu WY, Han B.

Zhonghua Zhong Liu Za Zhi. 2012 Oct;34(10):753-8. doi: 10.3760/cma.j.issn.0253-3766.2012.10.008. Chinese.

PMID:
23291069
3.
5.

Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.

Meguro M, Mizuguchi T, Nishidate T, Okita K, Ishii M, Ota S, Ueki T, Akizuki E, Hirata K.

World J Gastroenterol. 2015 Apr 28;21(16):4933-45. doi: 10.3748/wjg.v21.i16.4933.

6.
7.

α-fetoprotein, vascular endothelial growth factor receptor-1 and early recurrence of hepatoma.

Kamiyama T, Takahashi M, Nakanishi K, Yokoo H, Kamachi H, Kobayashi N, Ozaki M, Todo S.

World J Gastroenterol. 2012 Jan 28;18(4):340-8. doi: 10.3748/wjg.v18.i4.340.

8.

The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.

Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W.

Ann Surg Oncol. 2012 Oct;19(11):3556-65. doi: 10.1245/s10434-012-2396-1. Epub 2012 May 17.

PMID:
22588469
9.

Low CADM2 expression predicts high recurrence risk of hepatocellular carcinoma patients after hepatectomy.

Yang S, Yan HL, Tao QF, Yuan SX, Tang GN, Yang Y, Wang LL, Zhang YL, Sun SH, Zhou WP.

J Cancer Res Clin Oncol. 2014 Jan;140(1):109-16. doi: 10.1007/s00432-013-1536-8. Epub 2013 Nov 17.

PMID:
24240726
10.

Preoperative serum α-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma.

Yang SL, Liu LP, Yang S, Liu L, Ren JW, Fang X, Chen GG, Lai PB.

Br J Surg. 2016 May;103(6):716-724. doi: 10.1002/bjs.10093. Epub 2016 Mar 21.

PMID:
26996727
11.

Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?

Zhang Y, Song T, Meng L, Wu X, Ba Y, Li Q.

ANZ J Surg. 2009 Jan-Feb;79(1-2):62-9. doi: 10.1111/j.1445-2197.2008.04801.x.

PMID:
19183381
12.

Coexpression of stemness factors Oct4 and Nanog predict liver resection.

Yin X, Li YW, Zhang BH, Ren ZG, Qiu SJ, Yi Y, Fan J.

Ann Surg Oncol. 2012 Sep;19(9):2877-87. doi: 10.1245/s10434-012-2314-6. Epub 2012 Mar 30.

PMID:
22461131
13.

Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.

Blank S, Wang Q, Fiel MI, Luan W, Kim KW, Kadri H, Mandeli J, Hiotis SP.

Ann Surg Oncol. 2014 Mar;21(3):986-94.

PMID:
24232510
14.

Villin 1 is a predictive factor for the recurrence of high serum alpha-fetoprotein-associated hepatocellular carcinoma after hepatectomy.

Xieraili M, Yasen M, Mogushi K, Obulhasim G, Mayinuer A, Aihara A, Tanaka S, Mizushima H, Tanaka H, Arii S.

Cancer Sci. 2012 Aug;103(8):1493-501. doi: 10.1111/j.1349-7006.2012.02315.x. Epub 2012 May 25.

15.

Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy.

Zheng H, Yang Y, Wang MC, Yuan SX, Tian T, Han J, Ni JS, Wang J, Xing H, Zhou WP.

Surg Oncol. 2016 Sep;25(3):171-7. doi: 10.1016/j.suronc.2016.05.026. Epub 2016 May 24.

PMID:
27566019
16.

Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma.

Wang B, Xu T, Liu J, Zang S, Gao L, Huang A.

Pathol Res Pract. 2014 Dec;210(12):787-92. doi: 10.1016/j.prp.2014.09.014. Epub 2014 Oct 6.

PMID:
25445114
17.

Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.

Kamiyama T, Orimo T, Wakayama K, Shimada S, Nagatsu A, Yokoo H, Kamachi H, Yamashita K, Shimamura T, Taketomi A.

World J Surg Oncol. 2017 Aug 22;15(1):156. doi: 10.1186/s12957-017-1229-x.

18.

High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection.

Hu J, Xu Y, Shen ZZ, Wang Z, Lu Q, Yang GH, Ding ZB, Fan J, Zhou J.

J Cancer Res Clin Oncol. 2009 Oct;135(10):1359-67. doi: 10.1007/s00432-009-0577-5. Epub 2009 Apr 7. Erratum in: J Cancer Res Clin Oncol. 2009 Nov;135(11):1635-6.

PMID:
19350273
19.

Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.

Chung GE, Kim W, Lee JH, Kim YJ, Yoon JH, Lee JM, Lee JY, Kim SH, Kim D, Lee HS.

J Gastroenterol Hepatol. 2011 Nov;26(11):1638-45. doi: 10.1111/j.1440-1746.2011.06777.x.

PMID:
22011297
20.

Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.

Lu LL, Sun J, Lai JJ, Jiang Y, Bai LH, Zhang LD.

World J Gastroenterol. 2015 Jun 7;21(21):6649-59. doi: 10.3748/wjg.v21.i21.6649.

Supplemental Content

Support Center